濮阳东方看男科咨询怎么去濮阳东方妇科,濮阳东方看男科病很便宜,濮阳东方医院治阳痿口碑非常好,濮阳东方医院看早泄比较好,濮阳东方妇科在线预约,濮阳东方医院妇科专业,濮阳东方妇科技术可靠

EL CAJON, Calif. (KGTV) - When their friend was diagnosed with cancer, two El Cajon fifth-graders never imagined it would make her feel unwelcome at school. "She was coming back to school for half days because she was feeling a little bit better, and we heard that she was being bullied," said Wriley Lee, referring to her friend Trianne Nguyentu.Lee and another student, Matthew Stevens, decided they needed to do something to support Nguyentu. "Most people here don't really care what your appearance is, and after I heard about that, I said that's not right," said Lee.RELATED: San Diego grandmother grateful for man's random act of kindnessSo the Vista Grande Elementary students decided to shave their heads in solidarity. "Honestly, at first, I didn't believe them. I thought they were trying to get a rise out of me because it was so unexpected," said Principal Tita Cordero-Bautista. But the students were serious, so Cordero-Bautista teamed up with a school counselor to guide the students through the process.To teach more students a lesson in empathy and compassion, the counselor helped Lee and Stevens give an announcement to their classmates explaining their choice. "Appearance doesn't really matter; it just matters what's on the inside," said Lee. RELATED: Neighborhood 'angel' goes above and beyond to help othersPrincipal Cordero-Bautista says Nguyentu stopped by campus on Monday, confident and happy thanks to the actions of her peers.So far, a total of five kids have shaved their heads to support her. Nguyentu hopes to return to school next month. 1580

EL CAJON, Calif. (KGTV) -- An elderly man was struck by a car and killed as he crossed an El Cajon street Wednesday night.At around 11:30 p.m., El Cajon police and paramedics were called to the intersection of Jamacha and Main Street in response to a pedestrian hit by a vehicle.Police said a pickup truck was traveling northbound on Jamacha when it hit the 80 year-old-man. Officers say the victim's leg was amputated, and he was not breathing when they arrived at the scene.The victim, who was not identified, was taken to the hospital where he died from his injuries.According to police, the driver remained at the scene and was cooperating with investigators.Alcohol or drugs did not appear to be factors in the incident, police said. 746

Does a picture show a polar bear getting off a bus in Russia?No.The photo going around online is real. But it actually shows a realistic puppet operated by two people and used by Greenpeace. 198

Dr. Anthony Fauci delivered more good news regarding a potential coronavirus vaccine, indicating some Americans could begin getting vaccinated by the end of this month.During an interview with CNN’s Wolf Blitzer, Fauci, the director of the National Institute of Allergy and Infectious Diseases National Institute of Allergy and Infectious Diseases, said it’s possible a vaccine could begin reaching some Americans by the end of the month, but was confident some would begin getting vaccinated by the end of the year.Fauci’s declaration came on the same day Pfizer said that its Phase 3 vaccine candidate was showing an effectiveness of over 90%. Fauci said the announcement was promising, but a few more questions need to be addressed before it is given approval. Fauci said that things like the vaccine’s durability and effect on the elderly are among concerns that still need to be tackled.“We may have doses that we’re able to give to people by the end of November, beginning of December,” Fauci told CNN’s Blitzer. “Now you have to go through the hoops of making sure all of the I’s are dotted and the T’s are crossed about the safety and regulatory aspects of it, but we would be giving vaccine, very likely, by the end of this year. That is good news.”Last month, the FDA put into place guidelines on approving a vaccine, which was more restrictive than what the White House had hoped for. The FDA noted that a vaccine candidate must be at least 50% effective. Vaccine candidates should include a median follow-up duration of at least two months after completion of the full vaccination regimen to help provide adequate information to assess a vaccine’s risk-benefit.“In addition to outlining our expectations for vaccine sponsors, we also hope the agency's guidance on COVID-19 vaccines helps the public understand our science-based decision-making process that assures vaccine quality, safety and efficacy for any vaccine that is authorized or approved,” Peter Marks, M.D., Ph.D., director of the FDA's Center for Biologics Evaluation and Research, said.While it is possible some will begin getting vaccinated in the coming weeks or months, questions remain on how soon a majority of the country will have the opportunity to become vaccinated. The first Americans slated to become vaccinated will be health care workers and people with a high risk of coronavirus complications, such as the elderly and those living in assisted living facilities, according to an NPR report.Given that Pfizer’s vaccine candidate is showing a high level of effectiveness, Fauci called the development “extraordinary.”"We know there's light at the end of the tunnel, but that doesn't mean that we're going to give up the important public health measures that we continually still have to do every single day,” Fauci said.While there is urgency for both public health and economic reasons for a vaccine, some experts have expressed concern over the speed of a vaccine and whether the expedited timeline is long enough to demonstrate efficacy.Even though a vaccine could be ready by year’s end, trials will be expected to continue for over a year to monitor for possible side effects.According to the FDA, a typical Phase 3 trial would take one to three years.“NIH is committed to supporting several Phase 3 vaccine trials to increase the odds that one or more will be effective in preventing COVID-19 and put us on the road to recovery from this devastating pandemic,” said NIH Director Francis S. Collins, M.D., Ph.D. “We also know that preventing this disease could require multiple vaccines and we’re investing in those that we believe have the greatest potential for success.”Pfizer said based on current projections, it expects to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses in 2021. 3823

Earlier this week, Russian president Vladimir Putin said that his country has produced a vaccine against the coronavirus, but American-based experts have expressed concerns over the efficacy of the vaccine, and whether the country cut corners in its production.Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said in an interview with ABC News’ Deborah Roberts that he has concerns that the vaccine has not had a chance to be fully studied by scientists."I hope that the Russians have actually, definitively proven that the vaccine is safe and effective," Fauci said. "I seriously doubt that they've done that."Also in an interview with ABC News, Health and Human Services Secretary Alex Azar said that while the US hopes to have a vaccine produced soon, it’s important to have a one that is fully vetted by science.“The point is not to be first with a vaccine, the point is to have a vaccine that is safe and effective for the American people and the people of the world,” Azard told ABC.Russian Direct Investment Fund, which is a Russian governmental agency, says that the vaccine has quickly garnered demand throughout the world, with 20 countries requesting the vaccine."We can confirm that 1 billion is the request, actually slightly more than 1 billion, is the amount of preliminary requests we received from more than 20 countries so far,” Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said.While Putin did not confirm if he had taken the vaccine, he said that his daughter was received it.While the US has a number of ongoing trials, it appears that a vaccine is still months away from getting approved. And then getting a vaccine to millions of Americans could take additional time.President Donald Trump said he is ready to employ military resources in order to quickly distribute a COVID-19 vaccine. There is immense pressure on the US to produce a vaccine with more than 1,000 Americans dying from the coronavirus per day in recent weeks, according to Johns Hopkins University data.“I feel strongly that we will have a vaccine by the end of the year and it will be put in service maybe even as we get it because we are already set militarily, we are using our military to distribute the vaccine,” Trump said. 2284